Literature DB >> 30130344

One-Step Approach to Identifying Gestational Diabetes Mellitus: Association With Perinatal Outcomes.

Gaia Pocobelli1, Onchee Yu, Sharon Fuller, James R Fraser, Paige D Wartko, Lu Chen, Katherine M Newton, Jane Dimer, David K McCulloch, Susan Warwick, Sascha Dublin.   

Abstract

OBJECTIVE: To compare perinatal outcomes before and after a clinical guideline change from a two-step to a one-step approach to screening for gestational diabetes mellitus (GDM).
METHODS: We conducted a before-after cohort study of women with singleton live birth deliveries within Kaiser Permanente Washington, a mixed-model health plan in Washington state. We used Kaiser Permanente Washington electronic health data and linked birth certificates. We compared outcomes before (January 2009-March 2011) and after (April 2012-December 2014) the guideline change among women who received prenatal care from health care providers internal to Kaiser Permanente Washington (n=4,977 before, n=6,337 after). We made the same comparison among women who received prenatal care from external health care providers (not exposed to the guideline change; n=3,386 before, n=4,454 after) to control for time trends unrelated to the guideline change. Adjusted relative risks and 95% CIs were estimated using Poisson generalized estimating equations.
RESULTS: After the guideline change, receipt of the one-step approach became widespread among women cared for by Kaiser Permanente Washington internal providers (87%), and use of insulin increased 3.7-fold from 1.2% to 4.4%. Among women cared for by Kaiser Permanente Washington internal providers, GDM increased from 6.9% to 11.4%, induction of labor from 25.2% to 28.6%, neonatal hypoglycemia from 1.3% to 2.0%, and outpatient nonstress testing from 134.6 to 157.0 test days per 100 women. After accounting for background trends in outcomes (based on the women cared for by external providers), the guideline change was associated with increased incidence of GDM (relative risk [RR] 1.41, 95% CI 1.17-1.69), labor induction (RR 1.20, 95% CI 1.09-1.32), neonatal hypoglycemia (RR 1.77, 95% CI 1.14-2.75), and nonstress testing (RR 1.12, 95% CI 1.02-1.24% per 100 women). There was no association with other outcomes including cesarean delivery or macrosomia.
CONCLUSION: Adopting the one-step approach was associated with a 41% increase in the diagnosis of GDM without improved maternal or neonatal outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 30130344     DOI: 10.1097/AOG.0000000000002780

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Early Pregnancy Hemoglobin A1C and Pregnancy Outcomes: A Population-Based Study.

Authors:  Lu Chen; Gaia Pocobelli; Onchee Yu; Susan M Shortreed; Sarah S Osmundson; Sharon Fuller; Paige D Wartko; David Mcculloch; Susan Warwick; Katherine M Newton; Sascha Dublin
Journal:  Am J Perinatol       Date:  2018-11-30       Impact factor: 1.862

2.  Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.

Authors:  Sascha Dublin; Abisola Idu; Lyndsay A Avalos; T Craig Cheetham; Thomas R Easterling; Lu Chen; Victoria L Holt; Nerissa Nance; Zoe Bider-Canfield; Romain S Neugebauer; Kristi Reynolds; Sylvia E Badon; Susan M Shortreed
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.752

3.  Women's experiences of a diagnosis of gestational diabetes mellitus: a systematic review.

Authors:  Louise Craig; Rebecca Sims; Paul Glasziou; Rae Thomas
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-07       Impact factor: 3.007

Review 4.  Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications.

Authors:  Joon Ho Moon; Hak Chul Jang
Journal:  Diabetes Metab J       Date:  2022-01-27       Impact factor: 5.376

5.  Perinatal Outcomes of Two Screening Strategies for Gestational Diabetes Mellitus: A Randomized Controlled Trial.

Authors:  Esa M Davis; Kaleab Z Abebe; Hyagriv N Simhan; Patrick Catalano; Tina Costacou; Diane Comer; Steven Orris; Kathleen Ly; Alison Decker; Dara Mendez; Nancy Day; Christina M Scifres
Journal:  Obstet Gynecol       Date:  2021-07-01       Impact factor: 7.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.